Title |
Levetiracetam for neuropathic pain in adults
|
---|---|
Published in |
Cochrane database of systematic reviews, July 2014
|
DOI | 10.1002/14651858.cd010943.pub2 |
Pubmed ID | |
Authors |
Philip J Wiffen, Sheena Derry, R Andrew Moore, Michael PT Lunn |
Abstract |
Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. The efficacy of levetiracetam for relief of neuropathic pain has not previously been reviewed. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 27% |
Spain | 2 | 13% |
New Zealand | 1 | 7% |
Canada | 1 | 7% |
Bolivia, Plurinational State of | 1 | 7% |
Gibraltar | 1 | 7% |
Unknown | 5 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 87% |
Practitioners (doctors, other healthcare professionals) | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Spain | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 207 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 42 | 20% |
Student > Bachelor | 28 | 13% |
Student > Ph. D. Student | 19 | 9% |
Researcher | 16 | 8% |
Student > Doctoral Student | 11 | 5% |
Other | 30 | 14% |
Unknown | 64 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 69 | 33% |
Nursing and Health Professions | 27 | 13% |
Neuroscience | 10 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
Psychology | 6 | 3% |
Other | 18 | 9% |
Unknown | 70 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2019.
All research outputs
#1,584,945
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,382
of 11,842 outputs
Outputs of similar age
#15,390
of 240,440 outputs
Outputs of similar age from Cochrane database of systematic reviews
#64
of 225 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,440 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.